AAM
BMY icon

Alphadyne Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Alphadyne Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.77M Sell
95,200
-5,200
-5% -$303K 0.1% 273
2025
Q4 		$5.42M Buy
100,400
+83,800
+505% +$4.03M 0.13% 125
2025
Q3 		$749K Buy
+16,600
New +$775K 0.06% 216

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alphadyne Asset Management's BMY Position: Q4 2025 in Review

Alphadyne Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 3,982 shares — an estimated $192K sold.

Alphadyne Asset Management first reported a position in BMY in Q2 2023 and held it in 4 quarters. The position peaked at $663K in Q4 2023. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Alphadyne Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Alphadyne Asset Management sold 3,982 Bristol-Myers Squibb shares in Q4 2025, an estimated $192K.
  • Alphadyne Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 4 quarters.
  • Alphadyne Asset Management's Bristol-Myers Squibb position peaked at $663K in Q4 2023.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Alphadyne Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.